0778 Management of Shift Work Disorder an American Academy of Sleep Medicine Clinical Practice Guideline
Abstract
This guideline establishes recommendations for the treatment of shift work disorder (SWD).
The American Academy of Sleep Medicine (AASM) commissioned a task force of experts in sleep and circadian medicine to develop recommendations and assign strengths based on a systematic review of the literature and an assessment of the evidence using the GRADE process. The task force summarized the relevant literature and the quality of evidence, the balance of benefits and harms, patient values and preferences, and resource use considerations supporting the recommendations. The AASM Board of Directors approved the final recommendations.
The following recommendations are intended as a guide for clinicians in choosing specific treatment(s) for symptoms of excessive sleepiness and/or insomnia, and for circadian adaptation in adults with SWD. Each recommendation statement is assigned a strength (e.g., “Strong” or “Conditional”). For SWD, there were only “conditional” recommendations for or against (i.e., “We suggest…”) and those requiring the clinician to use clinical knowledge and experience and consider the individual patient’s values and preferences to determine the best course of action. Interventions in recommendation statements were compared to no treatment.
Adults with SWD with symptoms of excessive sleepiness associated with work schedule: 1. In adults with SWD with excessive sleepiness, the AASM suggests the use of armodafinil or modafinil taken 30 to 60 minutes prior to the night…
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.